HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dc07-2433v1 31/5/945    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Hwang, J. J. Articles by Mantzoros, C. S. PubMed PubMed Citation Articles by Hwang, J. J. Articles by Mantzoros, C. S. Social Bookmarking                What's this?

Leptin Does Not Directly Regulate the Pancreatic Hormones Amylin and Pancreatic Polypeptide

Interventional studies in humans

¹ Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
² Department of Nutrition and Dietetics, Harokopio University, Athens, Greece
³ Division of Developmental Medicine, Glasgow University, Glasgow, Scotland, U.K

Corresponding author: Dr. Christos Mantzoros, Division of Endocrinology, Diabetes, and Metabolism, 330 Brookline Ave., ST 816, Boston, MA 02215. E-mail: cmantzor{at}bidmc.harvard.edu

OBJECTIVE—Leptin and the pancreatic hormones amylin and pancreatic polypeptide are being evaluated alone or in combination for the treatment of obesity, but their physiological regulation has not yet been fully elucidated. Thus, we examined whether amylin and pancreatic polypeptide are regulated by caloric intake and/or short- and long-term energy deprivation and whether any potential regulation is mediated by changes in leptin levels.

RESEARCH DESIGN AND METHODS—We measured circulating levels of amylin and pancreatic polypeptide after 1) a 75-g glucose load in 28 healthy, normal-weight women, 2) 72-h complete energy deficiency (severe hypoleptinemia) with administration of either placebo or replacement-dose recombinant methionyl human leptin (r-metHuLeptin) in normal-weight men (n = 6) and women (n = 7), and 3) chronic mild energy deficiency (mild hypoleptinemia) in 7 women with hypothalamic amenorrhea before and after r-metHuLeptin administration for 3 months.

RESULTS—Amylin and pancreatic polypeptide levels increased 15 min after a 75-g glucose load and remained elevated at 60 and 120 min (P < 0.0001). Fasting for 72 h decreased leptin (to 21%) and amylin (to 67%) of baseline but not pancreatic polypeptide levels. Normalizing leptin levels with r-metHuLeptin did not alter the fasting-induced decrease in amylin and had no effect on pancreatic polypeptide levels. Neither amylin nor pancreatic polypeptide levels were different in leptin-deficient women with hypothalamic amenorrhea compared with weight-matched control subjects, and normalization of leptin levels with r-metHuLeptin treatment did not alter amylin or pancreatic polypeptide levels.

CONCLUSIONS—Circulating amylin levels increase after a glucose load and decrease in response to short-term complete fasting, but these changes are not mediated by leptin.

Abbreviations: AUC, area under the curve • BIDMC, Beth Israel Deaconess Medical Center • GCRC, General Clinical Research Center • OGTT, oral glucose tolerance test • r-metHuLeptin, recombinant methionyl human leptin

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?